ArticleHealth science reports2023

Comparison of recent updates in genetics, immunology, biomarkers, and neuroimaging of primary-progressive and relapsing-remitting multiple sclerosis and the role of ocrelizumab in the management of their refractory cases.

Priyadarshi Prajjwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.